Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-21-065434)

Filing Details

Accession Number:: 0001209191-21-065434
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-11-18 16:05:36
Reporting Period:: 2021-11-16

Accepted Time:: 2021-11-18 16:05:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1253689	Glycomimetics Inc	GLYC	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1445710	S Patricia Andrews	C/O Glycomimetics, Inc. 9708 Medical Center Drive Rockville MD 20850		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-11-16	40,000	$2.05	45,250	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The Reporting Person purchased the securities on the open market at purchase prices ranging from $2.03 to $2.07 per share, with a weighted average purchase price of $2.05 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.